PMID: 9556088Apr 29, 1998Paper

Idiopathic thrombocytopenic purpura: a guideline for diagnosis and management of children and adults. American Society of Hematology

Annals of Medicine
James N GeorgeG E Raskob

Abstract

Idiopathic thrombocytopenic purpura (ITP, also known as immune thrombocytopenic purpura) affects both children and adults. In childhood, the peak age is 2-4 years, girls and boys are equally affected, and in most children, the disease is self-limited with spontaneous recovery occurring in several weeks to several months. In adults, ITP is most common among young women, and the disease is more insidious in its onset and chronic in its course. In both children and adults, there are important unresolved issues in diagnosis and management that have major cost implications. For this reason, the American Society of Hematology chose ITP as the disease topic for its initial practice guideline in 1993. In 1996, the practice guideline was published in Blood, the Journal of the American Society of Hematology. This review describes the principle features of ITP in children and adults, the process of development of the practice guideline for ITP, and the implications of the guideline for the diagnosis and management of patients with ITP.

References

Oct 1, 1990·American Journal of Obstetrics and Gynecology·R F Burrows, J G Kelton
May 1, 1988·American Journal of Diseases of Children·D S Halperin, J J Doyle
Jul 1, 1986·American Journal of Public Health·R E ParkD H Solomon
Nov 3, 1994·The New England Journal of Medicine·J N GeorgeG E Raskob
Jun 1, 1994·Annals of Internal Medicine·S R TunisE P Steinberg
Nov 11, 1993·The New England Journal of Medicine·R F Burrows, J G Kelton
Feb 15, 1997·Annals of Internal Medicine·J N George, F Davidoff
Aug 1, 1997·Annals of Internal Medicine·D J CookS R Weingarten

❮ Previous
Next ❯

Citations

Aug 30, 2002·British Journal of Haematology·Giovanni EmiliaGiuseppe Torelli
Feb 17, 2000·Current Opinion in Pediatrics·D Medeiros, G R Buchanan
Oct 31, 2000·Current Opinion in Hematology·N Manny, O Zelig
Apr 1, 2008·Journal of Pediatric Hematology/oncology·Johannes R RischewskiKühne Thomas
Oct 18, 2012·Journal of Pediatric Hematology/oncology·John A D'OrazioNina Farhoudi
Oct 14, 2005·Paediatric Drugs·Aziza T ShadS G Sandler
Aug 11, 2011·Haematologica·Francesca RossiSilverio Perrotta
Oct 20, 2009·Current Medical Research and Opinion·Mansoor N SalehKelly M Grotzinger
Aug 28, 2004·International Journal of Paediatric Dentistry·B VaismanG Ramirez
Jul 29, 2005·Clinical and Laboratory Haematology·K M A Ramadan, M El-Agnaf
Dec 17, 2008·British Journal of Haematology·Ning-Ning ShanMing Hou
Feb 18, 2003·British Journal of Haematology·UNKNOWN British Committee for Standards in Haematology General Haematology Task Force
Apr 21, 2001·BMC Blood Disorders·Rafael NunezKarsten Feige
Nov 19, 2011·PloS One·Axel C MatzdorffSimone Hummler
May 4, 2005·Human Immunology·Feng Jin, Joseph P Balthasar
Apr 6, 2005·The American Journal of Medicine·Roberto StasiDrew Provan
Jul 4, 2006·Seminars in Hematology·James Bussel
Apr 18, 2008·Blood Reviews·Imad UthmanMunther Khamashta
Feb 4, 2005·The Journal of Pediatrics·Julie WangJames B Bussel
Aug 26, 2006·Pediatric Blood & Cancer·Johannes R RischewskiThomas Kühne
Feb 9, 2005·Pediatric Blood & Cancer·Victoria PriceMark Greenberg
Jan 24, 2009·Pediatric Blood & Cancer·George B Segel, Stephen A Feig
Oct 13, 2009·The Cochrane Database of Systematic Reviews·Arturo J Martí-CarvajalGabriella Comunián-Carrasco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.